| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/02/2009 | WO2009023697A3 Hollow silica nanospheres and methods of making same |
| 04/02/2009 | WO2009021656A3 Tablet containing donepezile hydrochloride in amorphous form |
| 04/02/2009 | WO2009020317A3 Stabilized antioxidant particles, composition comprising the same and method for preparing the same |
| 04/02/2009 | WO2009020314A3 Stabilized alpha-lipoic acid particles, composition comprising the same and method for preparing the same |
| 04/02/2009 | WO2009015112A3 Metal complexes incorporated within biodegradable nanoparticles and their use |
| 04/02/2009 | WO2009013356A3 Anti-hiv tablet formulations comprising darunavir |
| 04/02/2009 | WO2009010787A3 Stable pharmaceutical compositions comprising one or more hmg-coa reductase inhibitors |
| 04/02/2009 | WO2009007573A8 Method for preparing a granulated form |
| 04/02/2009 | WO2009007110A3 Combination of benzyl-4,5-dihydro-1h-imidazole derivative and an opiod recptor ligand |
| 04/02/2009 | WO2009004649A3 Enteric coated pharmaceutical compositions |
| 04/02/2009 | WO2009004214A3 Method for preparing lipid nanoparticles |
| 04/02/2009 | WO2008139313A3 Propofol transparent anaesthetic solution with low venous irritation |
| 04/02/2009 | WO2008110337A3 Pharmaceutical composition of quetiapine fumarate |
| 04/02/2009 | WO2008104846A3 Pharmaceutical compositions of fenofibrate |
| 04/02/2009 | WO2008094905A3 Encapsulated hdl mimetic peptides |
| 04/02/2009 | WO2008036595A3 Subunguicide, and method for treating onychomycosis |
| 04/02/2009 | WO2008027337A3 Compositions for reducing cell adhesion to bubbles |
| 04/02/2009 | WO2006044657A3 Phosphate binder with reduced pill burden |
| 04/02/2009 | WO2006042146A3 Multifunctional nanoparticles conjugates and their use |
| 04/02/2009 | WO2005112654A3 Compositions comprising edible oils and vitamins and/or minerals and methods for making the compositions |
| 04/02/2009 | WO2005067632A3 Lipid compositions and use thereof |
| 04/02/2009 | WO2005003180A3 A method for the production of emulsion-based micro particles |
| 04/02/2009 | US20090088732 Rapid Refill Programming for Implantable Drug Pump |
| 04/02/2009 | US20090088731 Infusion Device Menu Structure and Method of Using the Same |
| 04/02/2009 | US20090088679 Electronically-Degradable Layer-by-Layer Thin Films |
| 04/02/2009 | US20090088455 Chronic, Bolus Adminstration Of D-Threo Methylphenidate |
| 04/02/2009 | US20090088423 Methods and compositions for treating bacterial infections and diseases associated therewith |
| 04/02/2009 | US20090088415 Controlled release pharmaceutical compositions |
| 04/02/2009 | US20090088408 Pharmaceutical compositions on anticholinergics, corticosteroids and betamimetics |
| 04/02/2009 | US20090088382 Use of the cathelicidin LL-37 and derivatives therof for wound healing |
| 04/02/2009 | US20090087494 Methods and Compositions for Targeted Delivery of Therapeutic Agents |
| 04/02/2009 | US20090087493 Supramolecular Functionalization of Graphitic Nanoparticles for Drug Delivery |
| 04/02/2009 | US20090087492 Processes and Apparatuses for the Production of Crystalline Organic Microparticle Compositions by Micro-Milling and Crystallization on Micro-Seed and Their Use |
| 04/02/2009 | US20090087491 Method for preparing particles from an emulsion in supercritical or liquid co2 |
| 04/02/2009 | US20090087490 Extended release formulation and method of treating adrenergic dysregulation |
| 04/02/2009 | US20090087489 Imatinib compositions |
| 04/02/2009 | US20090087488 Galantamine-containing controlled release oral dosage forms, processes for the preparation thereof and use of the manufacture of a medicament |
| 04/02/2009 | US20090087487 Paliperidone sustained release formulation |
| 04/02/2009 | US20090087486 Foam Wafer Containing a Polyvinyl Alcohol-Polyethyleneglycol-Graft Copolymer |
| 04/02/2009 | US20090087485 Orally Disintegrating Tablets |
| 04/02/2009 | US20090087484 Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| 04/02/2009 | US20090087483 Oral dosage combination pharmaceutical packaging |
| 04/02/2009 | US20090087482 Temperature-Sensitive Liposomal Formulation |
| 04/02/2009 | US20090087481 Using mixture comprising colony stimulating factor, interleukin-5 and/or a mimetic as therapeutic tool in treatment of nervous system disorders |
| 04/02/2009 | US20090087480 Pharmaceutical composition and method using antifungal agent in combination |
| 04/02/2009 | US20090087479 Orally bioavailable lipid-based constructs |
| 04/02/2009 | US20090087478 Orally Deliverable and Anti-Toxin Antibodies and Methods for Making and Using Them |
| 04/02/2009 | US20090087477 Methods for preparing reverse micelles based on sterols and acylglycerols for the delivery of metal ions |
| 04/02/2009 | US20090087476 Pure polypeptide of sequence Tyr-Lys-Glu-Val-Thr-Lys-Leu-Ile-Asp-Asn-Asn-Lys-Thr-Glu-Lys-Glu-Ile-Leu; controlled release and liposome formulations |
| 04/02/2009 | US20090087475 Non-Wovens With High Interfacial Pore Size And Method Of Making Same |
| 04/02/2009 | US20090087473 Osteoinductive bone graft material and manufacturing method |
| 04/02/2009 | US20090087470 Subcutaneously implanting a device containing octreotide or acetate salt and hydroxpropylcellulose encased in a hydrophilic addition copolymer., e.g., hydroxyethyl- hydroxypropyl methacrylate; delivers octreotide over 6 months at a controlled rate to avoid the suffering of multiple periodic injections. |
| 04/02/2009 | US20090087465 Saline nose wipe and methods of manufacture and use |
| 04/02/2009 | US20090087462 Use of pyrimidine derivatives for cosmetic purposes |
| 04/02/2009 | US20090087460 Solid composition, microparticles, microparticle dispersion liquid, and manufacturing methods for these |
| 04/02/2009 | US20090087420 Stable solution of reduced coenzyme q |
| 04/02/2009 | US20090087408 Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device |
| 04/02/2009 | US20090087389 Dehydroepiandrosterone sulfate dihydrate inhalation compositions and methods |
| 04/02/2009 | US20090087388 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
| 04/02/2009 | US20090087387 (4aR,7S,7aR)-3-methoxy-4,7-dimethylhexahydrocyclopenta[c]pyran-1(3H)-one, useful as repellents for insects and arthropods |
| 04/02/2009 | US20090087386 Effervescent composition and method of making an effervescent composition including a viscous component |
| 04/02/2009 | US20090087385 Intranasally administering curcumin in a bolus of helium gas to treat alzheimers disease |
| 04/02/2009 | US20090087380 Polymer devices for therapeutic applications |
| 04/02/2009 | DE112007001104T5 Lumen-bewegliche Einheit Lumen portable unit |
| 04/02/2009 | DE112007001103T5 Lumen-bewegliche Abgabeeinheit Lumen mobile power unit |
| 04/02/2009 | DE102007046600A1 Verfahren zum Applizieren eines flüssigen, medizinischen Behandlungsmediums auf einen zu behandelden Bereich sowie Medizinprodukt A method of applying a liquid medium to a medical treatment to the area treated are and medical device |
| 04/02/2009 | DE102007045686A1 Verfahren zur Herstellung frei fließender, pulverförmiger Extrakte mit Hilfe der Wirbelschicht Trocknung A process for producing a free-flowing, powdered extracts using the fluidized-bed drying |
| 04/02/2009 | CA2709236A1 Pharmaceutical compositions of rhein or diacerein |
| 04/02/2009 | CA2704712A1 Orally bioavailable lipid-based constructs |
| 04/02/2009 | CA2704132A1 Pharmaceutical composition containing esomeprazole |
| 04/02/2009 | CA2701032A1 Pharmaceutical formulations |
| 04/02/2009 | CA2700983A1 Composition and method of stabilized sensitive ingredient |
| 04/02/2009 | CA2700892A1 Reagents for inducing an immune response |
| 04/02/2009 | CA2700844A1 Stable imatinib compositions |
| 04/02/2009 | CA2700808A1 Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo |
| 04/02/2009 | CA2700591A1 Controlled release tamsulosin hydrochloride tablets and a process of making them |
| 04/02/2009 | CA2700534A1 Treatment of pulmonary disorders with aerosolized medicaments such as vancomycin |
| 04/02/2009 | CA2700480A1 Orally-administered agent |
| 04/02/2009 | CA2700426A1 Compositions comprising lipophilic active compounds and method for their preparation |
| 04/02/2009 | CA2700386A1 Medical devices having a filter insert for controlled diffusion |
| 04/02/2009 | CA2699887A1 Microparticle comprising cross-linked polymer |
| 04/02/2009 | CA2698827A1 Makeup-assisting patch and makeup method using the patch |
| 04/02/2009 | CA2697629A1 Molecular delivery vesicle |
| 04/02/2009 | CA2697229A1 Galenical formulations of organic compounds |
| 04/01/2009 | EP2042599A1 Method of making microencapsulated DNA for vaccination and gene therapy |
| 04/01/2009 | EP2042538A1 Amphiphilic copolymers and compositions containing such polymers |
| 04/01/2009 | EP2042185A1 A two active principles-containing medicine for a targeted treatment of a carcinome |
| 04/01/2009 | EP2042184A1 Physiologically active polypeptide, polymer micelle having protein enclosed therein, and process for production of the polymer micelle |
| 04/01/2009 | EP2042180A1 Preparations containing phytosterol |
| 04/01/2009 | EP2042174A1 Adhesive preparation |
| 04/01/2009 | EP2042169A1 Controlled release tamsulosin hydrochloride tablets and a process of making them |
| 04/01/2009 | EP2042166A1 Nanocapsules for oral delivery of proteins |
| 04/01/2009 | EP2042165A1 Hot-melt filled soft capsules |
| 04/01/2009 | EP2042164A1 Stabilized solid preparation |
| 04/01/2009 | EP2042163A1 Pharmaceutical compositions comprising fluvastatin |
| 04/01/2009 | EP2042162A1 Process for producing spherical elementary granule containing readily water-soluble drug |
| 04/01/2009 | EP2042161A1 Propellant-free spray composition comprising anti-emetic agent |
| 04/01/2009 | EP2042160A1 Oral tablettes for the treatment of the oral cavity and the pharynx |
| 04/01/2009 | EP2042138A1 Patch and patch preparation |
| 04/01/2009 | EP2041196A2 Polymer |